Analysts expect Perrigo Company PLC (NYSE:PRGO) to post $1.28 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Twelve analysts have provided estimates for Perrigo’s earnings. The highest sales estimate is $1.34 billion and the lowest is $1.25 billion. Perrigo also posted sales of $1.28 billion during the same quarter last year. The company is expected to issue its next quarterly earnings results on Thursday, March 7th.
According to Zacks, analysts expect that Perrigo will report full-year sales of $4.84 billion for the current year, with estimates ranging from $4.81 billion to $4.85 billion. For the next fiscal year, analysts expect that the firm will report sales of $4.97 billion, with estimates ranging from $4.89 billion to $5.17 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Perrigo.
Perrigo (NYSE:PRGO) last released its quarterly earnings results on Thursday, November 8th. The company reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. The business had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.17 billion. Perrigo had a net margin of 4.77% and a return on equity of 11.92%. Perrigo’s revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.39 EPS.
A number of research analysts recently issued reports on PRGO shares. ValuEngine lowered shares of Perrigo from a “sell” rating to a “strong sell” rating in a research note on Friday, September 14th. Wells Fargo & Co lowered their target price on shares of Perrigo from $84.00 to $77.00 and set a “market perform” rating on the stock in a research note on Tuesday, August 21st. Cantor Fitzgerald reiterated a “buy” rating and issued a $107.00 target price on shares of Perrigo in a research note on Monday, October 8th. JPMorgan Chase & Co. lowered their target price on shares of Perrigo from $83.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, August 10th. Finally, Canaccord Genuity set a $90.00 target price on shares of Perrigo and gave the company a “buy” rating in a research note on Friday, August 17th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $87.80.
In related news, EVP Svend Andersen purchased 7,200 shares of the firm’s stock in a transaction on Tuesday, August 14th. The shares were bought at an average cost of $69.43 per share, for a total transaction of $499,896.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Todd W. Kingma purchased 3,200 shares of the firm’s stock in a transaction on Friday, November 9th. The stock was bought at an average price of $63.99 per share, for a total transaction of $204,768.00. Following the completion of the transaction, the vice president now directly owns 23,587 shares in the company, valued at $1,509,332.13. The disclosure for this purchase can be found here. Insiders acquired a total of 29,983 shares of company stock worth $1,950,822 over the last 90 days. Company insiders own 6.90% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of PRGO. LPL Financial LLC boosted its position in shares of Perrigo by 27.0% during the 1st quarter. LPL Financial LLC now owns 9,585 shares of the company’s stock valued at $799,000 after acquiring an additional 2,040 shares in the last quarter. Royal Bank of Canada boosted its position in shares of Perrigo by 176.4% during the 1st quarter. Royal Bank of Canada now owns 38,431 shares of the company’s stock valued at $3,203,000 after acquiring an additional 88,765 shares in the last quarter. Allianz Asset Management GmbH acquired a new stake in shares of Perrigo during the 1st quarter valued at about $205,000. State of Alaska Department of Revenue boosted its position in shares of Perrigo by 38.6% during the 2nd quarter. State of Alaska Department of Revenue now owns 35,743 shares of the company’s stock valued at $2,604,000 after acquiring an additional 9,950 shares in the last quarter. Finally, Xact Kapitalforvaltning AB boosted its position in shares of Perrigo by 10.7% during the 2nd quarter. Xact Kapitalforvaltning AB now owns 26,952 shares of the company’s stock valued at $1,965,000 after acquiring an additional 2,616 shares in the last quarter. Institutional investors own 83.00% of the company’s stock.
NYSE:PRGO opened at $64.07 on Friday. Perrigo has a 1 year low of $62.74 and a 1 year high of $95.93. The company has a current ratio of 1.81, a quick ratio of 1.23 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $10.11 billion, a P/E ratio of 13.00, a PEG ratio of 2.39 and a beta of 0.66.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 18th. Shareholders of record on Friday, November 30th will be given a $0.19 dividend. The ex-dividend date of this dividend is Thursday, November 29th. This represents a $0.76 annualized dividend and a yield of 1.19%. Perrigo’s dividend payout ratio is 15.42%.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Featured Story: What is the 52-week high/low?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.